Finasteride Induced Cerebral Venous Thrombosis

August 2015 in “ Journal of the Korean neurological association ”

Dong-Hyun Kang, Han-Gil Jeong, Hang-Rai Kim, Chan Beum Park, Jung Min Pyun, Yeon Sook Kim, Seung Hwan Lee

finasteride cerebral venous thrombosis estrone estradiol blood clot benign prostate hyperplasia hair loss dabigatran Propecia CVT BPH

TLDR A man had a rare stroke possibly due to taking finasteride, which might have increased his hormone levels causing a blood clot. His memory loss didn't fully recover even after stopping the medication.

In 2015, a 46-year-old man developed cerebral venous thrombosis (CVT), a rare form of stroke, after taking 5 mg of finasteride daily for two years for benign prostate hyperplasia, and an additional 1 mg daily for hair loss for one year. The finasteride was suspected to have increased the patient's levels of estrone and estradiol, potentially leading to a blood clot. After discontinuing finasteride and starting on dabigatran 110 mg bid, the patient's symptoms did not worsen, but his short-term memory loss had not fully recovered three months after discharge. The authors called for more research to establish a causal relationship between finasteride use and blood clot formation.

View this study on jkna.org →

Discuss this study in the Community →

Research cited in this study

2 / 2 results

research Two Cases of Stroke Associated with the Use of Finasteride, an Approved Drug for Male-Pattern Hair Loss in Japan

7 citations, January 2014 in “Rinshō shinkeigaku”

Finasteride, a hair loss medication, may be linked to stroke in young men.

research Finasteride-Induced Gynecomastia in a 62-Year-Old Man

15 citations, June 1995 in “The American Journal of the Medical Sciences”

Finasteride caused enlarged breast tissue in a 62-year-old man.

Related Community Posts Join

6 / 1000+ results

community 60 days on topical minoxidil 5% + 0.1% finasteride.

in Progress Pictures 377 upvotes 3 weeks ago

The user is happy with hair regrowth after 60 days using topical minoxidil 5% and finasteride 0.1%, along with a dermaroller. They report no significant side effects and plan to continue treatment for a year.

community People who tolerate dut better than fin?

in Finasteride/Dutasteride 32 upvotes 2 months ago

Dutasteride may have fewer side effects than finasteride, with some users experiencing better hair maintenance. Experiences vary, with some preferring dutasteride for fewer side effects, while others see no significant hair improvement.

community Just over 4 months in. Am I seeing things?

in Is this regrowth? 37 upvotes 1 year ago

The user reports potential hair regrowth after using finasteride nightly, minoxidil twice daily, occasional microneedling, and vitamin supplements, and is considering RU58841 in the future. Replies suggest they are seeing improvement.

community Bryan Johnson just dropped his anti hair loss formula

in Treatment 339 upvotes 10 months ago

Bryan Johnson shared his hair loss treatment, which mainly relies on minoxidil and finasteride. Some users are skeptical of his results, while others appreciate his efforts in anti-aging and hair loss research.

community Is it worth getting on oral minoxidil?

in Minoxidil 1 year ago

Evaluating the effectiveness of taking oral minoxidil as a hair loss treatment, in comparison to finasteride and topical minoxidil; discussing potential side effects of using oral minoxidil.

community Why I deleted my YouTube channel Part I

in Update 118 upvotes 3 years ago

A YouTuber named Kevin, also known as Rider_Of_Roach, who deleted his YouTube channel due to personal attacks and controversy surrounding his views on hair loss treatments. He advocated for FDA-approved treatments like finasteride and minoxidil but faced backlash from those who disagreed with him. The conversation also discusses his past trolling behavior and a lawsuit he filed against a website that published false information about him. Despite some disagreements, many viewers appreciated his research-based content and hope to see him return in the future.